Edward Gabrielson - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Oncology, Pathology, Molecular Biology

126 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Tully E, Bharti S, Woo J, Bhujwalla Z, Gabrielson E. Biguanide drugs enhance cytotoxic effects of cisplatin by depleting aspartate and NAD+ in sensitive cancer cells. Cancer Biology & Therapy. 1-8. PMID 34720054 DOI: 10.1080/15384047.2021.1982599  0.399
2021 Yan Y, Narayan A, Cho S, Cheng Z, Liu JO, Zhu H, Wang G, Wharram B, Lisok A, Brummet M, Saeki H, Huang T, Gabrielson K, Gabrielson E, Cope L, et al. CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer. Oncogene. PMID 34341513 DOI: 10.1038/s41388-021-01975-3  0.411
2020 Muniraj N, Siddharth S, Shriver M, Nagalingam A, Parida S, Woo J, Elsey J, Gabrielson K, Gabrielson E, Arbiser JL, Saxena NK, Sharma D. Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment. Cell Death Discovery. 6: 81. PMID 34483341 DOI: 10.1038/s41420-020-00315-w  0.409
2020 Zhou Y, Lih TM, Pan J, Höti N, Dong M, Cao L, Hu Y, Cho KC, Chen SY, Eguez RV, Gabrielson E, Chan DW, Zhang H, Li QK. Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets. Journal of Hematology & Oncology. 13: 170. PMID 33287876 DOI: 10.1186/s13045-020-01013-x  0.352
2020 Muniraj N, Siddharth S, Shriver M, Nagalingam A, Parida S, Woo J, Elsey J, Gabrielson K, Gabrielson E, Arbiser JL, Saxena NK, Sharma D. Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment. Cell Death Discovery. 6: 81. PMID 32963809 DOI: 10.1038/S41420-020-00315-W  0.502
2020 Shibata M, Ooki A, Inokawa Y, Sadhukhan P, Ugurlu MT, Izumchenko E, Munari E, Bogina G, Rudin CM, Gabrielson E, Singh A, Hoque MO. Concurrent Targeting of Potential Cancer Stem Cells Regulating Pathways Sensitizes Lung Adenocarcinoma to Standard Chemotherapy. Molecular Cancer Therapeutics. PMID 32847981 DOI: 10.1158/1535-7163.Mct-20-0024  0.42
2020 Zhou Y, Yang W, Ao M, Höti N, Gabrielson E, Chan DW, Zhang H, Li QK. Proteomic Analysis of the Air-Way Fluid in Lung Cancer. Detection of Periostin in Bronchoalveolar Lavage (BAL). Frontiers in Oncology. 10: 1072. PMID 32719746 DOI: 10.3389/fonc.2020.01072  0.369
2019 Zhang J, Ji Z, Caushi JX, El Asmar M, Anagnostou V, Cottrell TR, Chan HY, Suri P, Guo H, Merghoub T, Chaft JE, Reuss JE, Tam AJ, Blosser RL, Abu-Akeel M, ... ... Gabrielson E, et al. Compartmental analysis of T cell clonal dynamics as a function of pathologic response to neoadjuvant PD-1 blockade in resectable non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31754049 DOI: 10.1158/1078-0432.Ccr-19-2931  0.405
2019 Zhou Y, Gong G, Wang H, Habibabady ZA, Lang P, Hales R, Askin F, Gabrielson E, Li QK. Transthoracic fine-needle aspiration diagnosis of solid, subsolid, and partially calcified lung nodules: A retrospective study from a single academic center. Cytojournal. 16: 16. PMID 31516538 DOI: 10.4103/cytojournal.cytojournal_43_18  0.332
2019 Downs B, Mercado-Rodriguez C, Cimino-Mathews A, Chen C, Yuan J, Van Den Berg EJ, Cope L, Schmitt F, Tse GM, Ali SZ, Meir-Levi D, Sood R, Li J, Richardson AL, Mosunjac M, ... ... Gabrielson E, et al. DNA Methylation Markers for Breast Cancer Detection in the Developing World. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31300453 DOI: 10.1158/1078-0432.Ccr-18-3277  0.409
2019 Jafarnejad M, Gong C, Gabrielson E, Bartelink IH, Vicini P, Wang B, Narwal R, Roskos L, Popel AS. A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung Cancer. The Aaps Journal. 21: 79. PMID 31236847 DOI: 10.1208/S12248-019-0350-X  0.404
2019 Nguyen T, Kirsch BJ, Asaka R, Nabi K, Quinones A, Tan J, Antonio MJ, Camelo F, Li T, Nguyen S, Hoang G, Nguyen K, Udupa S, Sazeides C, Shen YA, ... ... Gabrielson E, et al. Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer. Cell Reports. 27: 491-501.e6. PMID 30970252 DOI: 10.1016/J.Celrep.2019.03.036  0.404
2019 Muniraj N, Siddharth S, Nagalingam A, Walker A, Woo J, Gyorffy B, Gabrielson E, Saxena NK, Sharma D. Withaferin A inhibits lysosomal activity to block autophagic flux and induces apoptosis via energetic impairment in breast cancer cells. Carcinogenesis. PMID 30698683 DOI: 10.1093/carcin/bgz015  0.395
2019 Sugimoto K, Ito T, Woo J, Tully E, Sato K, Orita H, Brock MV, Gabrielson E. Prognostic Impact of Phosphorylated Discoidin Domain Receptor-1 in Esophageal Cancer. The Journal of Surgical Research. 235: 479-486. PMID 30691832 DOI: 10.1016/J.Jss.2018.10.032  0.317
2019 Fackler M, Cho S, Cope L, Gabrielson E, Wilsbach K, Lynch C, Marks J, Geradts J, Regan M, Viale G, Wolff A, Umbricht C, Sukumar S. Abstract P4-08-09: DNA methylation markers predict recurrence-free interval in triple-negative breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-08-09  0.39
2018 Anagnostou V, Forde PM, White JR, Niknafs N, Hruban C, Naidoo J, Marrone KA, Sivakumar IKA, Bruhm DC, Rosner S, Phallen J, Leal A, Adleff V, Smith KN, Cottrell TR, ... ... Gabrielson E, et al. Dynamics of tumor and immune responses during immune checkpoint blockade in non-small cell lung cancer. Cancer Research. PMID 30541742 DOI: 10.1158/0008-5472.Can-18-1127  0.364
2018 Wu X, Zahari MS, Renuse S, Sahasrabuddhe NA, Chaerkady R, Kim MS, Fackler MJ, Stampfer M, Gabrielson E, Sukumar S, Pandey A. Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts. Clinical Proteomics. 15: 21. PMID 29946230 DOI: 10.1186/S12014-018-9197-X  0.412
2018 Singh A, Ruiz C, Bhalla K, Haley JA, Li QK, Acquaah-Mensah G, Montal E, Sudini KR, Skoulidis F, Wistuba II, Papadimitrakopoulou V, Heymach JV, Boros LG, Gabrielson E, Carretero J, et al. De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancer. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201800204. PMID 29906244 DOI: 10.1096/Fj.201800204  0.359
2018 Forde PM, Chaft JE, Smith KN, Anagnostou V, Cottrell TR, Hellmann MD, Zahurak M, Yang SC, Jones DR, Broderick S, Battafarano RJ, Velez MJ, Rekhtman N, Olah Z, Naidoo J, ... ... Gabrielson E, et al. Neoadjuvant PD-1 Blockade in Resectable Lung Cancer. The New England Journal of Medicine. PMID 29658848 DOI: 10.1056/Nejmoa1716078  0.367
2018 Walker A, Singh A, Tully E, Woo J, Le A, Nguyen T, Biswal S, Sharma D, Gabrielson E. Nrf2 signaling and autophagy are complementary in protecting breast cancer cells during glucose deprivation. Free Radical Biology & Medicine. PMID 29649567 DOI: 10.1016/J.Freeradbiomed.2018.04.009  0.368
2018 Marrone KA, Zhou X, Forde PM, Purtell M, Brahmer JR, Hann CL, Kelly RJ, Coleman B, Gabrielson E, Rosner GL, Ettinger DS. A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer. The Oncologist. PMID 29487223 DOI: 10.1634/theoncologist.2017-0465  0.339
2018 Samanta D, Park Y, Ni X, Li H, Zahnow CA, Gabrielson E, Pan F, Semenza GL. Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 29367423 DOI: 10.1073/Pnas.1718197115  0.39
2018 Cottrell TR, Stein JE, Chaft JE, Thompson ED, Rekhtman N, Anagnostou V, Smith KN, Duffield AS, Anders RA, Isbell JM, Jones DR, Cuda JD, Battafarano R, Yang SC, Illei PB, ... Gabrielson E, et al. Abstract LB-154: Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small cell lung carcinoma (NSCLC): A proposal for quantitative immune-related pathologic response criteria (irPRC) Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-154  0.371
2018 Shabihkhani M, Yang W, Ao M, Gabrielson E, Askin F, Zhang H, Li QK. Proteomic Analysis of Bronchoalveolar Lavage (BAL) Specimens to Uncover Inflammatory Pathways in NSCLC (Non-small Cell Lung Carcinoma) and SCLC (Small Cell Lung Carcinoma). Moving from Genetic Targeted Therapy to Immunotherapy Journal of the American Society of Cytopathology. 7. DOI: 10.1016/J.Jasc.2018.06.185  0.376
2017 Osmani L, Askin F, Gabrielson E, Li QK. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy. Seminars in Cancer Biology. PMID 29183778 DOI: 10.1016/j.semcancer.2017.11.019  0.366
2017 Vaz M, Hwang SY, Kagiampakis I, Phallen J, Patil A, O'Hagan HM, Murphy L, Zahnow CA, Gabrielson E, Velculescu VE, Easwaran HP, Baylin SB. Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations. Cancer Cell. 32: 360-376.e6. PMID 28898697 DOI: 10.1016/J.Ccell.2017.08.006  0.388
2017 Huang P, Park S, Yan R, Lee J, Chu LC, Lin CT, Hussien A, Rathmell J, Thomas B, Chen C, Hales R, Ettinger DS, Brock M, Hu P, Fishman EK, ... Gabrielson E, et al. Added Value of Computer-aided CT Image Features for Early Lung Cancer Diagnosis with Small Pulmonary Nodules: A Matched Case-Control Study. Radiology. 162725. PMID 28872442 DOI: 10.1148/Radiol.2017162725  0.388
2017 Chung SJ, Nagaraju GP, Nagalingam A, Muniraj N, Kuppusamy P, Walker A, Woo J, Győrffy B, Gabrielson E, Saxena NK, Sharma D. ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis. Autophagy. 1-18. PMID 28696138 DOI: 10.1080/15548627.2017.1332565  0.392
2017 Lilo MT, Allison DB, Younes BK, Cui M, Askin FB, Gabrielson E, Li QK. The critical role of EBUS-TBNA cytology in the staging of mediastinal lymph nodes in lung cancer patients: A correlation study with positron emission tomography findings. Cancer. PMID 28609021 DOI: 10.1002/Cncy.21886  0.329
2017 Anagnostou V, Smith KN, Forde PM, Niknafs N, Bhattacharya R, White J, Adleff V, Phallen J, Wali N, Hruban C, Guthrie VB, Rodgers K, Naidoo J, Kang H, Sharfman W, ... ... Gabrielson E, et al. Abstract NG01: Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Ng01  0.461
2016 Anagnostou V, Smith KN, Forde PM, Niknafs N, Bhattacharya R, White J, Zhang T, Adleff V, Phallen J, Wali N, Hruban C, Guthrie VB, Rodgers K, Naidoo J, Kang H, ... ... Gabrielson E, et al. Evolution of Neoantigen Landscape During Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. Cancer Discovery. PMID 28031159 DOI: 10.1158/2159-8290.Cd-16-0828  0.381
2016 Wu X, Zahari MS, Renuse S, Kelkar DS, Bharbuiya MA, Rojas PL, Stearns V, Gabrielson E, Malla P, Sukumar S, Mahajan NP, Pandey A. The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer. Oncotarget. PMID 27902967 DOI: 10.18632/Oncotarget.13579  0.401
2016 Lilo MT, Allison D, Wang Y, Ao M, Gabrielson E, Geddes S, Zhang H, Askin F, Li QK. Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations. Journal of the American Society of Cytopathology : Jasc. 5: 123-132. PMID 27699149 DOI: 10.1016/j.jasc.2015.07.002  0.337
2016 Zhang C, Zhi WI, Lu H, Samanta D, Chen I, Gabrielson E, Semenza GL. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells. Oncotarget. PMID 27590511 DOI: 10.18632/Oncotarget.11743  0.481
2016 Sharma R, Wang Y, Chen L, Gurda GT, Geddes S, Gabrielson E, Askin F, Li QK. Utility of a Novel Triple Marker (Combination of TTF-1, Napsin-A and P40) in the Subclassification of Non-Small Cell Lung Carcinomas using Fine Needle Aspiration Cases. Human Pathology. PMID 27045515 DOI: 10.1016/J.Humpath.2016.02.027  0.417
2016 Allison DB, Lilo MT, Geddes S, Pallavajjalla A, Askin F, Gabrielson E, Zheng G, Li QK. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases. Cancer Cytopathology. PMID 27007084 DOI: 10.1002/Cncy.21714  0.354
2016 Zhi W, Huang C, Gabrielson E, Tully E, Cimino-Mathews A, Santa-Maria C, Jeter S, Kai C, Semenza G, Stearns V. Abstract P3-07-62: Association of overexpression of hypoxia inducible factor 1α with response to neoadjuvant chemotherapy in early stage breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P3-07-62  0.397
2016 Connolly R, Elkin E, Timms K, Goetz M, Boughey J, Zhang Z, Walsh B, Carpenter J, Storniolo A, Watkins S, Gabrielson E, Hartman A, Stearns V. Abstract P3-07-13: Homologous recombination deficiency (HRD) as a predictive biomarker of response to preoperative systemic therapy (PST) in TBCRC008 comprising a platinum in HER2-negative primary operable breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P3-07-13  0.422
2015 Wu X, Zahari MS, Ma B, Liu R, Renuse S, Sahasrabuddhe NA, Chen L, Chaerkady R, Kim MS, Zhong J, Jelinek C, Barbhuiya MA, Leal-Rojas P, Yang Y, Kashyap MK, ... ... Gabrielson E, et al. Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways. Oncotarget. PMID 26356563 DOI: 10.18632/Oncotarget.5020  0.488
2015 Wu X, Zahari MS, Renuse S, Nirujogi RS, Kim MS, Manda SS, Stearns V, Gabrielson E, Sukumar S, Pandey A. Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer. Molecular & Cellular Proteomics : McP. 14: 2887-900. PMID 26330541 DOI: 10.1074/Mcp.M115.050484  0.436
2015 Jhaveri TZ, Woo J, Shang X, Park BH, Gabrielson E. AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer. Oncotarget. 6: 14754-65. PMID 26143491 DOI: 10.18632/Oncotarget.4474  0.393
2015 Calmon MF, Jeschke J, Zhang W, Dhir M, Siebenkäs C, Herrera A, Tsai HC, O'Hagan HM, Pappou EP, Hooker CM, Fu T, Schuebel KE, Gabrielson E, Rahal P, Herman JG, et al. Epigenetic silencing of neurofilament genes promotes an aggressive phenotype in breast cancer. Epigenetics. 10: 622-32. PMID 25985363 DOI: 10.1080/15592294.2015.1050173  0.377
2015 Gurda GT, Zhang L, Wang Y, Chen L, Geddes S, Cho WC, Askin F, Gabrielson E, Li QK. Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases. Clinical and Translational Medicine. 4: 16. PMID 25977750 DOI: 10.1186/S40169-015-0057-2  0.356
2014 Wu X, Zahari MS, Renuse S, Jacob HK, Sakamuri S, Singal M, Gabrielson E, Sukumar S, Pandey A. A breast cancer cell microarray (CMA) as a rapid method to characterize candidate biomarkers. Cancer Biology & Therapy. 15: 1593-9. PMID 25535895 DOI: 10.4161/15384047.2014.961886  0.464
2014 Kanaan YM, Sampey BP, Beyene D, Esnakula AK, Naab TJ, Ricks-Santi LJ, Dasi S, Day A, Blackman KW, Frederick W, Copeland RL, Gabrielson E, Dewitty RL. Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive disease. Cancer Genomics & Proteomics. 11: 279-94. PMID 25422359  0.302
2014 Rodriguez E, Chen L, Ao MH, Geddes S, Gabrielson E, Askin F, Zhang H, Li QK. Expression of transcript factors SALL4 and OCT4 in a subset of non-small cell lung carcinomas (NSCLC). Translational Respiratory Medicine. 2: 10. PMID 25346886 DOI: 10.1186/s40247-014-0010-7  0.324
2014 Wu X, Renuse S, Sahasrabuddhe NA, Zahari MS, Chaerkady R, Kim MS, Nirujogi RS, Mohseni M, Kumar P, Raju R, Zhong J, Yang J, Neiswinger J, Jeong JS, Newman R, ... ... Gabrielson E, et al. Activation of diverse signalling pathways by oncogenic PIK3CA mutations. Nature Communications. 5: 4961. PMID 25247763 DOI: 10.1038/Ncomms5961  0.321
2014 Ao MH, Zhang H, Sakowski L, Sharma R, Illei PB, Gabrielson E, Askin F, Li QK. The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer. Human Pathology. 45: 926-34. PMID 24746197 DOI: 10.1016/J.Humpath.2014.01.005  0.461
2014 Rodić N, Sharma R, Sharma R, Zampella J, Dai L, Taylor MS, Hruban RH, Iacobuzio-Donahue CA, Maitra A, Torbenson MS, Goggins M, Shih IeM, Duffield AS, Montgomery EA, Gabrielson E, et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. The American Journal of Pathology. 184: 1280-6. PMID 24607009 DOI: 10.1016/J.Ajpath.2014.01.007  0.455
2014 Zhang H, Geddes S, Askin F, Gabrielson E, Li QK. Validation of Protein Biomarkers in Bronchoalveolar Lavage (BAL) to Improve the Detection of Lung Cancers in Patients with Lung Nodules Journal of the American Society of Cytopathology. 3: S83. DOI: 10.1016/J.JASC.2014.09.194  0.307
2014 Carter J, Geddes S, Zhang Z, Zhang H, Askin F, Gabrielson E, Li QK. Correlation of p16 Expression with p53, Cyclin D1 as Well as Clinical Outcomes in Non-small Cell Lung Carcinoma (NSCLC) Journal of the American Society of Cytopathology. 3. DOI: 10.1016/J.Jasc.2014.09.149  0.342
2013 Cheung KJ, Gabrielson E, Werb Z, Ewald AJ. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell. 155: 1639-51. PMID 24332913 DOI: 10.1016/J.Cell.2013.11.029  0.389
2013 Li Y, Wang X, Ao M, Gabrielson E, Askin F, Zhang H, Li QK. Aberrant Mucin5B expression in lung adenocarcinomas detected by iTRAQ labeling quantitative proteomics and immunohistochemistry. Clinical Proteomics. 10: 15. PMID 24176033 DOI: 10.1186/1559-0275-10-15  0.392
2013 Pei Z, Fraisl P, Shi X, Gabrielson E, Forss-Petter S, Berger J, Watkins PA. Very long-chain acyl-CoA synthetase 3: overexpression and growth dependence in lung cancer. Plos One. 8: e69392. PMID 23936004 DOI: 10.1371/Journal.Pone.0069392  0.542
2013 Li QK, Shah P, Li Y, Aiyetan PO, Chen J, Yung R, Molena D, Gabrielson E, Askin F, Chan DW, Zhang H. Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma. Journal of Proteome Research. 12: 3689-96. PMID 23802180 DOI: 10.1021/Pr400274W  0.478
2013 Stearns V, Jacobs LK, Fackler M, Tsangaris TN, Rudek MA, Higgins M, Lange J, Cheng Z, Slater SA, Jeter SC, Powers P, Briest S, Chao C, Yoshizawa C, Sugar E, ... ... Gabrielson E, et al. Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4008-16. PMID 23719261 DOI: 10.1158/1078-0432.Ccr-13-0033  0.351
2013 Li QK, Gabrielson E, Askin F, Chan DW, Zhang H. Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge. Proteomics. Clinical Applications. 7: 55-69. PMID 23112109 DOI: 10.1002/prca.201200105  0.383
2013 Bardia A, Santa-Maria CA, Jacobs LK, Cimino-Mathews A, Huang P, Russell S, Camp M, Habibi M, Lange JR, Jeter S, Powers P, Slater S, Gabrielson E, Carducci MA, Semenza G, et al. Digoxin as an inhibitor of global hypoxia inducible factor-1α (HIF1α) expression and downstream targets in breast cancer: Dig-HIF1 pharmacodynamic trial. Journal of Clinical Oncology. 31: TPS1144-TPS1144. DOI: 10.1200/Jco.2013.31.15_Suppl.Tps1144  0.347
2013 Jhaveri T, Woo JH, Gabrielson E. Abstract 5414: AMPK regulates HER2/EGFR activity in HER2-positive breast cancer. Cancer Research. 73: 5414-5414. DOI: 10.1158/1538-7445.Am2013-5414  0.427
2012 Kombairaju P, Ma J, Thimmulappa RK, Yan SG, Gabrielson E, Singh A, Biswal S. Prolonged sulforaphane treatment does not enhance tumorigenesis in oncogenic K-ras and xenograft mouse models of lung cancer. Journal of Carcinogenesis. 11: 8. PMID 22919281 DOI: 10.4103/1477-3163.98459  0.387
2012 Li QK, Gabrielson E, Zhang H. Application of glycoproteomics for the discovery of biomarkers in lung cancer. Proteomics. Clinical Applications. 6: 244-56. PMID 22641610 DOI: 10.1002/prca.201100042  0.405
2012 Bishop JA, Ogawa T, Chang X, Illei PB, Gabrielson E, Pai SI, Westra WH. HPV analysis in distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. The American Journal of Surgical Pathology. 36: 142-8. PMID 22173119 DOI: 10.1097/Pas.0B013E3182395C7B  0.317
2012 Rodriguez E, Geddes S, Gabrielson E, Askin F, Li QK. Expression of Cancer Stem Cell Transcription Factor SALL4 in Non-small Cell Lung Carcinomas (NSCLC) Journal of the American Society of Cytopathology. 1. DOI: 10.1016/J.Jasc.2012.08.188  0.459
2011 Stearns V, Mori T, Jacobs LK, Khouri NF, Gabrielson E, Yoshida T, Kominsky SL, Huso DL, Jeter S, Powers P, Tarpinian K, Brown RJ, Lange JR, Rudek MA, Zhang Z, et al. Preclinical and clinical evaluation of intraductally administered agents in early breast cancer. Science Translational Medicine. 3: 106ra108. PMID 22030751 DOI: 10.1126/Scitranslmed.3002368  0.402
2011 Konishi H, Mohseni M, Tamaki A, Garay JP, Croessmann S, Karnan S, Ota A, Wong HY, Konishi Y, Karakas B, Tahir K, Abukhdeir AM, Gustin JP, Cidado J, Wang GM, ... ... Gabrielson E, et al. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 17773-8. PMID 21987798 DOI: 10.1073/Pnas.1110969108  0.306
2011 Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, Shih IeM, Iacobuzio-Donahue CA, Maitra A, Li QK, Eberhart CG, et al. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. The American Journal of Pathology. 179: 1608-15. PMID 21888887 DOI: 10.1016/J.Ajpath.2011.06.018  0.372
2011 Lemmon CR, Woo JH, Tully E, Wilsbach K, Gabrielson E. Nuclear factor-kappaB (NF-kappaB) mediates a protective response in cancer cells treated with inhibitors of fatty acid synthase. The Journal of Biological Chemistry. 286: 31457-65. PMID 21768098 DOI: 10.1074/Jbc.M111.274308  0.722
2011 Jacobs MA, Ouwerkerk R, Wolff AC, Gabrielson E, Warzecha H, Jeter S, Bluemke DA, Wahl R, Stearns V. Monitoring of neoadjuvant chemotherapy using multiparametric, 23Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer Breast Cancer Research and Treatment. 128: 119-126. PMID 21455671 DOI: 10.1007/S10549-011-1442-1  0.322
2011 Daniel J, Coulter J, Woo JH, Wilsbach K, Gabrielson E. High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells Proceedings of the National Academy of Sciences of the United States of America. 108: 5384-5389. PMID 21402910 DOI: 10.1073/Pnas.1007645108  0.739
2011 Li QK, Singh A, Biswal S, Askin F, Gabrielson E. KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma. Journal of Human Genetics. 56: 230-4. PMID 21248763 DOI: 10.1038/Jhg.2010.172  0.319
2010 Orita H, Coulter J, Tully E, Abe M, Montgomery E, Alvarez H, Sato K, Hino O, Kajiyama Y, Tsurumaru M, Gabrielson E. High levels of fatty acid synthase expression in esophageal cancers represent a potential target for therapy Cancer Biology and Therapy. 10: 549-554. PMID 20657182 DOI: 10.4161/Cbt.10.6.12727  0.758
2010 Marik R, Fackler M, Gabrielson E, Zeiger MA, Sukumar S, Stearns V, Umbricht CB. DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer Biology & Therapy. 10: 44-53. PMID 20431345 DOI: 10.4161/Cbt.10.1.11994  0.452
2010 Blake DJ, Singh A, Kombairaju P, Malhotra D, Mariani TJ, Tuder RM, Gabrielson E, Biswal S. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. American Journal of Respiratory Cell and Molecular Biology. 42: 524-36. PMID 19520915 DOI: 10.1165/Rcmb.2009-0054Oc  0.371
2010 Stearns V, Jacobs LK, Tsangaris TN, Cheng Z, Slater S, Fackler MJ, Chao C, Bugarini R, Gabrielson E, Davidson NE. Association of vorinostat with decrease in gene expression of proliferation-related genes in tumors from women with newly diagnosed breast cancer. Journal of Clinical Oncology. 28: 3097-3097. DOI: 10.1200/JCO.2010.28.15_SUPPL.3097  0.315
2010 Orita H, Coulter J, Tully E, Montgomery E, Abe M, Maekawa H, Sato K, Tsurumaru M, Hino O, Gabrielson E. Abstract 5457: High levels of fatty acid synthase expression in esophageal cancers represent a potential target for therapy Cancer Research. 70: 5457-5457. DOI: 10.1158/1538-7445.Am10-5457  0.752
2009 Stearns V, Jacobs LK, Tsangaris TN, Briest S, Lange JR, Slater S, Fackler M, Sugar E, Gabrielson E, Davidson NE. A pilot study evaluating surrogates of response to short-term vorinostat in women with newly diagnosed breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e14508. PMID 27963537 DOI: 10.1200/jco.2009.27.15_suppl.e14508  0.35
2009 Yu W, Kanaan Y, Bae YK, Baed YK, Gabrielson E. Chromosomal changes in aggressive breast cancers with basal-like features. Cancer Genetics and Cytogenetics. 193: 29-37. PMID 19602461 DOI: 10.1016/J.Cancergencyto.2009.03.017  0.39
2008 Singh A, Boldin-Adamsky S, Thimmulappa RK, Rath SK, Ashush H, Coulter J, Blackford A, Goodman SN, Bunz F, Watson WH, Gabrielson E, Feinstein E, Biswal S. RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Research. 68: 7975-84. PMID 18829555 DOI: 10.1158/0008-5472.Can-08-1401  0.758
2008 Orita H, Coulter J, Tully E, Kuhajda FP, Gabrielson E. Inhibiting fatty acid synthase for chemoprevention of chemically induced lung tumors Clinical Cancer Research. 14: 2458-2464. PMID 18413838 DOI: 10.1158/1078-0432.Ccr-07-4177  0.73
2008 Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glöckner S, Piantadosi S, Gabrielson E, Pridham G, Pelosky K, Belinsky SA, Yang SC, Baylin SB, Herman JG. DNA methylation markers and early recurrence in stage I lung cancer. The New England Journal of Medicine. 358: 1118-28. PMID 18337602 DOI: 10.1056/Nejmoa0706550  0.457
2008 Suzuki H, Toyota M, Carraway H, Caraway H, Gabrielson E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T, Mori M, Hirata K, Imai K, Shinomura Y, et al. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. British Journal of Cancer. 98: 1147-56. PMID 18283316 DOI: 10.1038/Sj.Bjc.6604259  0.465
2008 Sukumar S, Stearns V, Khouri N, Jacobs L, Jeter S, Powers P, Rudek M, Gabrielson E, Zhang Z, Tsangaris T. Abstract CN13-03: Intraductal route of breast cancer prevention and therapy: from preclinical studies to Phase I trials Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-Cn13-03  0.438
2008 Suzuki H, Toyota M, Carraway H, Gabrielson E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T, Mori M, Hirata K, Imai K, Shinomura Y, Baylin SB, et al. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer (British Journal of Cancer (2008) 98, (1147-1156) DOI: 10.1038/sj.bjc.6604259) British Journal of Cancer. 99: 384. DOI: 10.1038/Sj.Bjc.6604507  0.475
2007 Woo JH, Li D, Wilsbach K, Orita H, Coulter J, Tully E, Taeg KK, Xu S, Gabrielson E. Coix seed extract, a commonly used treatment for cancer in China, inhibits NFκB and protein kinase C signaling Cancer Biology and Therapy. 6: 2005-2011. PMID 18087221 DOI: 10.4161/Cbt.6.12.5168  0.724
2007 Orita H, Coulter J, Lemmon C, Tully E, Vadlamudi A, Medghalchi SM, Kuhajda FP, Gabrielson E. Selective inhibition of fatty acid synthase for lung cancer treatment Clinical Cancer Research. 13: 7139-7145. PMID 18056164 DOI: 10.1158/1078-0432.Ccr-07-1186  0.758
2007 Orita H, Coulter J, Tully E, Pinn M, Thupari J, Pomper M, Townsend C, Ettinger D, Kuhajda F, Gabrielson E. Second-generation inhibitors of fatty acid synthase for lung cancer treatment Journal of Clinical Oncology. 25: 18185-18185. DOI: 10.1200/Jco.2007.25.18_Suppl.18185  0.383
2006 Mao TL, Hsu CY, Yen MJ, Gilks B, Sheu JJ, Gabrielson E, Vang R, Cope L, Kurman RJ, Wang TL, Shih IeM. Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma. Human Pathology. 37: 1169-75. PMID 16938522 DOI: 10.1016/j.humpath.2006.04.008  0.302
2006 Gabrielson E. Worldwide trends in lung cancer pathology. Respirology (Carlton, Vic.). 11: 533-8. PMID 16916324 DOI: 10.1111/J.1440-1843.2006.00909.X  0.47
2006 Yuan B, Xu Y, Woo JH, Wang Y, Bae YK, Yoon DS, Wersto RP, Tully E, Wilsbach K, Gabrielson E. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 405-10. PMID 16428479 DOI: 10.1158/1078-0432.Ccr-05-0903  0.432
2005 Bae YK, Shim YR, Choi JH, Kim MJ, Gabrielson E, Lee SJ, Hwang TY, Shin SO. Gene promoter hypermethylation in tumors and plasma of breast cancer patients. Cancer Research and Treatment : Official Journal of Korean Cancer Association. 37: 233-40. PMID 19956520 DOI: 10.4143/Crt.2005.37.4.233  0.398
2005 Fujii H, Gabrielson E, Takagaki T, Ohtsuji M, Ohtsuji N, Hino O. Frequent down-regulation of HIVEP2 in human breast cancer. Breast Cancer Research and Treatment. 91: 103-12. PMID 15868437 DOI: 10.1007/S10549-004-5779-6  0.453
2005 Lim JH, Kim SP, Gabrielson E, Park YB, Park JW, Kwon TK. Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation. International Journal of Cancer. 116: 200-6. PMID 15800911 DOI: 10.1002/Ijc.21007  0.427
2005 Makino H, Tajiri T, Miyashita M, Sasajima K, Anbazhagan R, Johnston J, Gabrielson E. Differential expression of TCEAL1 in esophageal cancers by custom cDNA microarray analysis. Diseases of the Esophagus : Official Journal of the International Society For Diseases of the Esophagus / I.S.D.E. 18: 37-40. PMID 15773840 DOI: 10.1111/J.1442-2050.2005.00432.X  0.438
2005 Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E, Corse A, Rosen A. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. The Journal of Experimental Medicine. 201: 591-601. PMID 15728237 DOI: 10.1084/Jem.20041367  0.337
2004 Guo M, Akiyama Y, House MG, Hooker CM, Heath E, Gabrielson E, Yang SC, Han Y, Baylin SB, Herman JG, Brock MV. Hypermethylation of the GATA genes in lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 7917-24. PMID 15585625 DOI: 10.1158/1078-0432.Ccr-04-1140  0.379
2004 Bae YK, Brown A, Garrett E, Bornman D, Fackler MJ, Sukumar S, Herman JG, Gabrielson E. Hypermethylation in histologically distinct classes of breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 5998-6005. PMID 15447983 DOI: 10.1158/1078-0432.Ccr-04-0667  0.453
2004 Gabrielson E, Tully E, Hacker A, Pegg AE, Davidson NE, Casero RA. Induction of spermidine/spermine N1-acetyltransferase in breast cancer tissues treated with the polyamine analogue N1, N11-diethylnorspermine. Cancer Chemotherapy and Pharmacology. 54: 122-6. PMID 15138709 DOI: 10.1007/S00280-004-0786-1  0.399
2004 Parmigiani G, Garrett E, Anbazhagan R, Gabrielson E. Molecular classification of lung cancer: a cross-platform comparison of gene expression data sets. Chest. 125: 103S. PMID 15136439 DOI: 10.1378/Chest.125.5_Suppl.103S  0.436
2004 Parmigiani G, Garrett-Mayer ES, Anbazhagan R, Gabrielson E. A cross-study comparison of gene expression studies for the molecular classification of lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2922-7. PMID 15131026 DOI: 10.1158/1078-0432.Ccr-03-0490  0.471
2004 Nikitin AY, Alcaraz A, Anver MR, Bronson RT, Cardiff RD, Dixon D, Fraire AE, Gabrielson EW, Gunning WT, Haines DC, Kaufman MH, Linnoila RI, Maronpot RR, Rabson AS, Reddick RL, et al. Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Research. 64: 2307-16. PMID 15059877 DOI: 10.1158/0008-5472.Can-03-3376  0.304
2004 Douglas DB, Akiyama Y, Carraway H, Belinsky SA, Esteller M, Gabrielson E, Weitzman S, Williams T, Herman JG, Baylin SB. Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer. Cancer Research. 64: 1611-20. PMID 14996719 DOI: 10.1158/0008-5472.Can-0318-2  0.317
2004 Meeker AK, Hicks JL, Gabrielson E, Strauss WM, De Marzo AM, Argani P. Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. The American Journal of Pathology. 164: 925-35. PMID 14982846 DOI: 10.1016/S0002-9440(10)63180-X  0.375
2004 Yu NA, Alcaraz A, Anver MR, Bronson RT, Cardiff RD, Dixon D, Fraire AE, Gabrielson E, Gunning WT, Haines DC, Kaufman MH, Linnoila RI, Maronpot RR, Rabson AS, Reddick RL, et al. Erratum: Classification of proliferative pulmonary lesions of the mouse: Recommendations of the mouse models of human cancers consortium (Cancer Research (April 1, 2004) 64 (2307-2316)) Cancer Research. 64. DOI: 10.1158/0008-5472.Can-64-10-Cor  0.433
2003 Porter D, Weremowicz S, Chin K, Seth P, Keshaviah A, Lahti-Domenici J, Bae YK, Monitto CL, Merlos-Suarez A, Chan J, Hulette CM, Richardson A, Morton CC, Marks J, Duyao M, ... ... Gabrielson E, et al. A neural survival factor is a candidate oncogene in breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 100: 10931-6. PMID 12953101 DOI: 10.1073/Pnas.1932980100  0.303
2003 Ohira T, Gemmill RM, Ferguson K, Kusy S, Roche J, Brambilla E, Zeng C, Baron A, Bemis L, Erickson P, Wilder E, Rustgi A, Kitajewski J, Gabrielson E, Bremnes R, et al. WNT7a induces E-cadherin in lung cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 100: 10429-34. PMID 12937339 DOI: 10.1073/Pnas.1734137100  0.305
2003 Yang Yu, Morin PJ, Han WF, Chen T, Bornman DM, Gabrielson EW, Pizer ES. Regulation of fatty acid synthase expression in breast cancer by sterol regulatory element binding protein-1c. Experimental Cell Research. 282: 132-7. PMID 12531699 DOI: 10.1016/S0014-4827(02)00023-X  0.365
2003 Ohira T, Gemmill RM, Roche J, Brambilla E, Rustgi A, Kitajewski J, Gabrielson E, Bremnes R, Franklin W, Drabkin HA. O-135 WNT7a induces E-cadherin in lung cancer Lung Cancer. 41. DOI: 10.1016/S0169-5002(03)91793-4  0.413
2002 Fujii H, Anbazhagan R, Bornman DM, Garrett ES, Perlman E, Gabrielson E. Mucinous cancers have fewer genomic alterations than more common classes of breast cancer. Breast Cancer Research and Treatment. 76: 255-60. PMID 12462386 DOI: 10.1023/A:1020808020873  0.434
2002 Yoon DS, Wersto RP, Zhou W, Chrest FJ, Garrett ES, Kwon TK, Gabrielson E. Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. The American Journal of Pathology. 161: 391-7. PMID 12163363 DOI: 10.1016/S0002-9440(10)64194-6  0.396
2002 Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma Cancer Research. 62: 3971-3979. PMID 12124329  0.367
2002 Zhou W, Lin Y, Wersto R, Chrest J, Gabrielson E. Staurosporine-induced G(1) arrest in cancer cells depends on an intact pRB but is independent of p16 status. Cancer Letters. 183: 103-7. PMID 12049820 DOI: 10.1016/S0304-3835(02)00101-5  0.499
2002 Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG, Baylin SB. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nature Genetics. 31: 141-9. PMID 11992124 DOI: 10.1038/Ng892  0.308
2002 Gabrielson E, Argani P. Heterogeneity in the Pathology and Molecular Biology of Breast Cancer Current Genomics. 3: 477-488. DOI: 10.2174/1389202023350327  0.319
2001 Bornman DM, Mathew S, Alsruhe J, Herman JG, Gabrielson E. Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. The American Journal of Pathology. 159: 831-5. PMID 11549575 DOI: 10.1016/S0002-9440(10)61758-0  0.376
2001 Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene. 20: 3348-53. PMID 11423985 DOI: 10.1038/Sj.Onc.1204438  0.425
2001 Pei J, Balsara BR, Li W, Litwin S, Gabrielson E, Feder M, Jen J, Testa JR. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes, Chromosomes & Cancer. 31: 282-7. PMID 11391799 DOI: 10.1002/Gcc.1145  0.318
2001 Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Ljung BM, Davidson NE, Sukumar S. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR The Lancet. 357: 1335-1336. PMID 11343741 DOI: 10.1016/S0140-6736(00)04501-3  0.404
2001 Shin SO, Lee KH, Kim JH, Baek SH, Park JW, Gabrielson EW, Kwon TK. Alternative splicing in 5'-untranslational region of STK-15 gene, encoding centrosome associated kinase, in breast cancer cell lines. Experimental & Molecular Medicine. 32: 193-6. PMID 11190269 DOI: 10.1038/emm.2000.31  0.321
2000 Gabrielson E. Genomic approaches to research in lung cancer. Respiratory Research. 1: 36-9. PMID 11667963 DOI: 10.1186/Rr10  0.461
2000 Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB, Herman JG. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. Journal of the National Cancer Institute. 92: 564-9. PMID 10749912 DOI: 10.1093/Jnci/92.7.564  0.343
1999 Anbazhagan R, Merlo A, Sidran-Sky D, Gabrielson E. Absence of intragenic mismatch mutations in small cell lung cancers with microsatellite instability International Journal of Cancer. 80: 944-945. PMID 10074930 DOI: 10.1002/(Sici)1097-0215(19990315)80:6<944::Aid-Ijc22>3.0.Co;2-9  0.456
1998 Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis Proceedings of the National Academy of Sciences of the United States of America. 95: 11891-11896. PMID 9751761 DOI: 10.1073/Pnas.95.20.11891  0.442
1998 Trink B, Pai SI, Spunt SL, Raman V, Cairns P, Jen J, Gabrielson E, Sukumar S, Sidransky D. Absence of TSG101 transcript abnormalities in human cancers Oncogene. 16: 2815-2818. PMID 9652749 DOI: 10.1038/Sj.Onc.1201795  0.385
1998 Fujii H, Biel MA, Zhou W, Weitzman SA, Baylin SB, Gabrielson E. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene. 16: 2159-64. PMID 9572497 DOI: 10.1038/Sj.Onc.1201976  0.444
1996 Fujii H, Zhou W, Gabrielson E. Detection of frequent allelic loss of 6q23–q25.2 in microdissected human breast cancer tissues Genes, Chromosomes and Cancer. 16: 35-39. PMID 9162195 DOI: 10.1002/(Sici)1098-2264(199605)16:1<35::Aid-Gcc5>3.0.Co;2-4  0.422
1994 Yu XY, Schofield BH, Croxton T, Takahashi N, Gabrielson EW, Spannhake EW. Physiologic modulation of bronchial epithelial cell barrier function by polycationic exposure American Journal of Respiratory Cell and Molecular Biology. 11: 188-198. PMID 8049079 DOI: 10.1165/Ajrcmb.11.2.8049079  0.313
Show low-probability matches.